• The Story Behind Imatinib, the First Targeted Cancer Treatment

  • May 6 2025
  • Length: 27 mins
  • Podcast

The Story Behind Imatinib, the First Targeted Cancer Treatment

Listen for free

View show details

  • Summary

  • Before the early 2000s, there were no effective treatments for chronic myelogenous leukemia, a blood cancer. Then came Imatinib. This drug dramatically improved survival and quality of life for patients with this disease. It also ushered in a new era of cancer treatment, with drugs that directly target tumor cells. In this episode, Chuck and Alicia talk with Dr. Brian Druker, a renowned physician scientist who was the main force behind the development of Imatinib.
    Show More Show Less
Show More Show Less
activate_mytile_page_redirect_t1

What listeners say about The Story Behind Imatinib, the First Targeted Cancer Treatment

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.